Clinical investigation of human plasma-derived von Willebrand factor products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/BPWG/220/02
Effective from01/06/2006
KeywordsVon Willebrand factor, von Willebrand disease
DescriptionThis document summarises the clinical trials required for authorisation of new and modified human plasma derived von Willebrand factor products.

Related content

How helpful is this page?

Average rating:

 Based on 15 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
3 ratings

Tell us more